文献速递主动脉疾病

t-Branch现成多分支支架腔内修复胸腹主动脉瘤的系统综述与荟萃分析

Systematic review and meta-analysis of published studies on endovascular repair of thoracoabdominal aortic aneurysms with the t-Branch off-the-shelf multibranched endograft.
PubMed 文献 · J Vasc Surg · 2020-04-01

该系统综述与荟萃分析纳入7项回顾性研究共197例患者,评估t-Branch现成多分支支架腔内修复胸腹主动脉瘤的效果。汇总技术成功率92.75%,早期死亡率5.8%,脊髓缺血率12.2%,永久性截瘫率1.3%,分支原发通畅率98.2%。结论认为该支架对择期和急诊患者是可行且安全的治疗选择。

要点

  • t-Branch支架汇总技术成功率达92.75%,分支原发通畅率98.2%。
  • 早期死亡率5.8%,脊髓缺血率12.2%,永久性截瘫率仅1.3%。
  • 尽管45%为症状性、19%为破裂病例,结果仍可接受。

核心结论

  • t-Branch现成多分支支架腔内修复胸腹主动脉瘤技术成功率良好,死亡率和神经系统并发症可接受,对择期和急诊患者是可行且安全的治疗选择。

研究设计与样本

  • 系统检索医学数据库,纳入2014至2018年发表的7项回顾性研究,共197例患者(平均年龄72.3±7岁,70%男性)。

主要发现

  • 汇总技术成功率为92.75%(95%CI 83.9%-98.7%),早期内漏发生率为10%(95%CI 0%-43.7%)。
  • 早期死亡率为5.8%(95%CI 2.5%-10%),主要卒中发生率为4%(95%CI 0.96%-8.40%)。
  • 脊髓缺血率为12.2%(95%CI 4.1%-23.2%),永久性截瘫率为1.3%(95%CI 0%-8.7%)。
  • 急性肾功能衰竭率为18.7%(95%CI 9.1%-30.4%),分支原发通畅率为98.2%(95%CI 96.7%-99.2%)。
  • 平均随访15±7个月,中期死亡率(30天后)为6.9%(95%CI 2.44%-12.8%),再干预率为5.7%(95%CI 1.70%-11.4%)。

关键数值与推荐

  • 在165例患者中,45%为症状性,19%因破裂主动脉瘤接受治疗。

临床怎么用

  • 对于择期和急诊胸腹主动脉瘤患者,t-Branch现成多分支支架可作为避免定制支架生产延迟的可行治疗选择。

局限性

  • 仅纳入回顾性研究,可能存在选择偏倚和异质性;平均随访时间较短(15±7个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular treatment of thoracoabdominal aortic aneurysms is becoming increasingly popular in clinical practice, mainly because of its reduced perioperative mortality and morbidity. However, the custom-made stent graft platform that companies offer requires detailed preoperative planning and production time that can take up to 12 weeks. This may delay surgery in elective patients and is not an option for urgent or emergent cases. To surpass this limitation, the t-Branch (Cook Medical, Bloomington, Ind) was launched in 2012 in Europe as the first off-the-shelf standardized multibranched endograft for the endovascular treatment of thoracoabdominal aneurysms. Our aim was to systematically evaluate all published experience with this commercially available off-the-shelf thoracoabdominal stent graft. METHODS: We performed a systematic inquiry of the medical databases to identify all published studies that reported on the outcomes of patients treated with the t-Branch stent graft and then conducted a qualitative synthesis and meta-analysis of the results. The main end points studied were technical success, mortality, major stroke, spinal cord ischemia, primary branch patency, and renal insufficiency during the first 30 days along with midterm mortality and reintervention rate. We estimated pooled proportions and 95% confidence intervals (CIs). RESULTS: We identified seven retrospective studies published between 2014 and 2018, with a total of 197 patients (mean age, 72.3 ± 7 years; 70% male). Among 165 patients, 45% were symptomatic and 19% were treated for a ruptured aortic aneurysm. In 197 patients, pooled technical success was 92.75% (95% CI, 83.9%-98.7%), and in 10% of the cases, an early endoleak was detected (95% CI, 0%-43.7%). Early mortality was 5.8% (95% CI, 2.5%-10%), and major stroke was observed in 4% of the patients (95% CI, 0.96%-8.40%). The rate of spinal cord ischemia was 12.2% (95% CI, 4.1%-23.2%), with the rate of permanent paraplegia at 1.3% (95% CI, 0%-8.7%). Acute renal failure was 18.7% (95% CI, 9.1%-30.4%), whereas primary branch patency was calculated at 98.2% (95% CI, 96.7%-99.2%). Mean follow-up was 15 ± 7 months. During this time, midterm mortality (after 30 days) was 6.9% (95% CI, 2.44%-12.8%) and pooled reintervention rate was 5.7% (95% CI, 1.70%-11.4%). CONCLUSIONS: This pooled analysis indicated good technical success rate after t-Branch endograft implantation, with acceptable mortality and neurologic complications despite a high rate of urgent procedures. Thoracoabdominal endovascular repair with the t-Branch endograft is a feasible and safe therapeutic option for elective and urgent patients.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Konstantinou N, Antonopoulos CN, Jerkku T, et al. Systematic review and meta-analysis of published studies on endovascular repair of thoracoabdominal aortic aneurysms with the t-Branch off-the-shelf multibranched endograft. J Vasc Surg. 2020. PMID: 32247700. doi:10.1016/j.jvs.2020.01.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。